130 related articles for article (PubMed ID: 38740134)
1. Asthma control in the United States: relationships between short-acting β
Chupp G; Murphy KR; Gandhi HN; Gilbert I; Bleecker ER
Ann Allergy Asthma Immunol; 2024 May; ():. PubMed ID: 38740134
[TBL] [Abstract][Full Text] [Related]
2. The use of short-acting bronchodilators and cost burden of asthma across Global Initiative for Asthma-based severity levels: Insights from a large US commercial and managed Medicaid population.
Pollack M; Gandhi H; Tkacz J; Lanz M; Lugogo N; Gilbert I
J Manag Care Spec Pharm; 2022 Aug; 28(8):881-891. PubMed ID: 35708342
[No Abstract] [Full Text] [Related]
3. Real-world patterns and implications of short-acting β
Lugogo N; Gilbert I; Tkacz J; Gandhi H; Goshi N; Lanz MJ
Ann Allergy Asthma Immunol; 2021 Jun; 126(6):681-689.e1. PubMed ID: 33515710
[TBL] [Abstract][Full Text] [Related]
4. Over-prescription of short-acting β
Chakaya J; Mecha J; Beekman M
BMC Prim Care; 2023 Jul; 24(1):141. PubMed ID: 37422638
[TBL] [Abstract][Full Text] [Related]
5. Short-acting β
Yorgancıoğlu A; Aksu K; Naycı SA; Ediger D; Mungan D; Gül U; Beekman MJHI;
BMC Pulm Med; 2022 Jun; 22(1):216. PubMed ID: 35655251
[TBL] [Abstract][Full Text] [Related]
6. Short-Acting Beta-2-Agonist Exposure and Severe Asthma Exacerbations: SABINA Findings From Europe and North America.
Quint JK; Arnetorp S; Kocks JWH; Kupczyk M; Nuevo J; Plaza V; Cabrera C; Raherison-Semjen C; Walker B; Penz E; Gilbert I; Lugogo NL; van der Valk RJP;
J Allergy Clin Immunol Pract; 2022 Sep; 10(9):2297-2309.e10. PubMed ID: 35364341
[TBL] [Abstract][Full Text] [Related]
7. Over-prescription of short-acting β
Smith C; Ambaram A; Mitha E; Abdullah I; Abdullah IA; Reddy J; Trokis J; Ramlachan P; Govind U; Lightfoot K; Moodley K; Smit R; Beekman MJHI
Afr J Thorac Crit Care Med; 2022; 28(4):. PubMed ID: 36874189
[TBL] [Abstract][Full Text] [Related]
8. Over-prescription of short-acting β
Alzaabi A; Al Busaidi N; Pradhan R; Shandy F; Ibrahim N; Ashtar M; Khudadah K; Hegazy K; Samir M; Negm M; Farouk H; Al Khalidi A; Beekman M
Asthma Res Pract; 2022 Jul; 8(1):3. PubMed ID: 35799290
[TBL] [Abstract][Full Text] [Related]
9. Short-acting beta-2 agonist prescription patterns and clinical outcomes in Chinese patients with asthma: an observational study in mainland China for the SABINA programme.
Bao W; Zhang Y; Hang J; Guo Y; Tang W; Yun C; Deng J; Jin M; Lai K; Yu H; Beekman M; Zhou X; Zhang M
Ther Adv Respir Dis; 2022; 16():17534666221115054. PubMed ID: 36065527
[TBL] [Abstract][Full Text] [Related]
10. Short-acting β
Theerakittikul T; Nakwan N; Niyompattama A; Siriphan P; Beekman MJHI
J Asthma; 2023 Dec; 60(12):2177-2188. PubMed ID: 37405933
[TBL] [Abstract][Full Text] [Related]
11. Overprescription of short-acting β
Al Zaabi A; Busaidi N; Al Mutairy S; Yorgancıoğlu A; Aksu K; Al-Jahdali H; Wali S; Elsayed M; Beekman MJ
Expert Rev Respir Med; 2022 Jul; 16(7):833-847. PubMed ID: 35848074
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of overuse of short-acting beta-2 agonists (SABA) and associated factors among patients with asthma in Germany.
Worth H; Criée CP; Vogelmeier CF; Kardos P; Becker EM; Kostev K; Mokros I; Schneider A
Respir Res; 2021 Apr; 22(1):108. PubMed ID: 33863317
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Moderate and Severe Asthma Exacerbations in the CAPTAIN Study.
Oppenheimer J; Kerstjens HA; Boulet LP; Hanania NA; Kerwin E; Moore A; Nathan RA; Peachey G; Pizzichini E; Slade D; Zarankaite A; Pavord ID
J Allergy Clin Immunol Pract; 2024 May; ():. PubMed ID: 38777124
[TBL] [Abstract][Full Text] [Related]
14. Short-acting β
Ban AY; Vengadasalam P; Taher SW; Mohd Zim MA; Sirol Aflah SS; Daut UN; Hyder Ali IA; Pereirasamy L; Omar A; Ibrahim A; Mohd Tarekh NA; Chan SK; Ali N; Mohd Isa NA; Hussain H; Abdul Karim N; Raja Gopal V; Chiam SY; Beekman MJHI
Malays Fam Physician; 2023; 18():32. PubMed ID: 37292227
[TBL] [Abstract][Full Text] [Related]
15. SABA Overuse in Russia - Burden and Possible Causes: An Analysis of the Russian Population in the SABINA III (SABA use IN Asthma) Study.
Avdeev S; Voznesenskiy N; Boldina M; Ignatova G; Kostina N; Kulbaisov A; Leshchenko I; Beekman MJHI
J Asthma Allergy; 2022; 15():371-379. PubMed ID: 35368426
[TBL] [Abstract][Full Text] [Related]
16. Over-prescription of short-acting β
Khattab A; Madkour A; Ambaram A; Smith C; Muhwa CJ; Mecha JO; Alsayed M; Beekman MJHI
Curr Med Res Opin; 2022 Nov; 38(11):1983-1995. PubMed ID: 36031882
[TBL] [Abstract][Full Text] [Related]
17. As-needed ICS-LABA in Mild Asthma: What Does the Evidence Say?
Domingo C; Rello J; Sogo A
Drugs; 2019 Nov; 79(16):1729-1737. PubMed ID: 31584145
[TBL] [Abstract][Full Text] [Related]
18. Seasonal patterns of controller and rescue medication dispensed in underserved children with asthma.
Butz AM; Thompson RE; Tsoukleris MG; Donithan M; Hsu VD; Mudd K; Zuckerman IH; Bollinger ME
J Asthma; 2008 Nov; 45(9):800-6. PubMed ID: 18972299
[TBL] [Abstract][Full Text] [Related]
19. A Cross-Sectional Study on Prescription Patterns of Short-Acting β
Pedrozo-Pupo JC; Pacheco Gallego MC; Baños Álvarez IJ; Jaller Raad RA; Caballero Pinilla AC; Reynales Londoño H; Bernal Villada L; Beekman M
J Asthma Allergy; 2022; 15():1167-1178. PubMed ID: 36051434
[TBL] [Abstract][Full Text] [Related]
20. SABINA: An Overview of Short-Acting β
Janson C; Menzies-Gow A; Nan C; Nuevo J; Papi A; Quint JK; Quirce S; Vogelmeier CF
Adv Ther; 2020 Mar; 37(3):1124-1135. PubMed ID: 31981105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
